Avance Clinical News
- Avance Clinical Launches Dedicated Center Of Excellence To Accelerate Early Phase Biotech Trials 10/21/2025
-
Avance Clinical Accelerates Time To Pivotal Milestones For More Than 700 Emerging Biotechs
9/30/2025
Avance Clinical, a partner for biotechs providing global contract research organization services, has now guided 710 emerging biotechs through critical clinical trial inflection points.
-
Avance Clinical Attends Reception Welcoming Australia's US Ambassador To North Carolina Governor's Executive Mansion In Raleigh, N.C.
9/30/2025
Avance Clinical was honored to attend a special reception at the Executive Mansion in Raleigh, North Carolina, hosted by Governor Josh Stein to welcome His Excellency, The Honorable Kevin Rudd AC, Australia’s Ambassador to the United States.
-
Avance Clinical Strengthens Korea Focus: Seoul Meeting Highlights Growth, Partnerships, And Regional Collaboration
9/30/2025
Avance Clinical, a global CRO headquartered in South Australia, met with Mr Jeff Robinson, South Australian Ambassador to Korea, to advance collaboration opportunities between South Australia and Korea in biotech clinical research.
-
Meet Avance Clinical At 2025 KoNECT-MOHW-MFDS International Conference (KIC)
7/15/2025
This prestigious conference is a premier platform for biotech and pharma companies to explore emerging trends, regulatory developments, and innovations shaping the future of clinical trials across Asia and around the world.
-
Meet Avance Clinical At BIO Asia-Taiwan 2025
7/15/2025
This year’s program features Business Partnering, Exhibitions, and Conferences, offering insights into emerging bio-health trends, technologies, and global expansion strategies. Our team is looking forward to connecting with biotech leaders in Taiwan to discuss tailored solutions across the drug development lifecycle.
-
Australia Delivers Certainty For US Biotechs In 2025: Avance Clinical Offers Fast Start-Up, Regulatory Predictability, And R&D Rebates
5/28/2025
As regulatory uncertainty grows in the United States, US biotechs are increasingly looking to Australia as a stable and predictable launchpad for early-phase clinical trials. With its globally accepted regulatory framework, accelerated timelines, and 43.5% R&D rebate, Australia offers a compelling advantage — and Avance Clinical, Australia’s leading early-phase specialist CRO, is delivering the GlobalReady solution to help biotechs de-risk, conserve capital and accelerate their programs.
-
Meet With Avance Clinical At ASCO 2025 In Chicago
5/20/2025
Avance Clinical will attend and host a booth at the upcoming American Society of Clinical Oncology (ASCO) Annual Meeting, scheduled from May 30 to June 3, 2025, at McCormick Place in Chicago, Illinois. This premier event brings together oncology professionals from around the world to connect, collaborate, and inspire advancements in cancer care.
-
Avance Clinical Honored With Frost & Sullivan's 2025 Global Customer Value Leadership Award
5/20/2025
Frost & Sullivan has named Avance Clinical the recipient of its 2025 Global Customer Value Leadership Award in the biotech contract research organization (CRO) sector, highlighting the company’s outstanding performance in delivering exceptional client value through innovation, service excellence, and technology-enabled trial optimization.
-
Avance Clinical To Showcase Asia-Pacific Clinical Trial Expertise At BIO Korea 2025
4/15/2025
Avance Clinical, a leading full-service global Contract Research Organization (CRO) specializing in high-quality, agile clinical biotech research services, will attend BIO Korea 2025 to meet with biotechs and share clinical trial capabilities across the region including Australia, New Zealand, South Korea, Taiwan, North America and beyond.